Literature DB >> 25293661

NeuroThera Effectiveness and Safety Trial 3: how do we align corporate and scientific integrity to complete and report pharma-sponsored trials properly?

Steven R Levine1, Michael D Hill2.   

Abstract

Keywords:  Editorials; clinical trials phase III; ethics; scientific integrity review

Mesh:

Year:  2014        PMID: 25293661     DOI: 10.1161/STROKEAHA.114.006750

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  3 in total

1.  Photobiomodulation for Global Cerebral Ischemia: Targeting Mitochondrial Dynamics and Functions.

Authors:  Ruimin Wang; Yan Dong; Yujiao Lu; Wenli Zhang; Darrell W Brann; Quanguang Zhang
Journal:  Mol Neurobiol       Date:  2018-06-27       Impact factor: 5.590

2.  A cost-effective rabbit embolic stroke bioassay: insight into the development of acute ischemic stroke therapy.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2015-02-01       Impact factor: 6.829

3.  Translational Medicine - A Multidisciplinary, Collaborative and Global Effort.

Authors:  Wei Lu; Wuwei Feng
Journal:  Transl Perioper Pain Med       Date:  2015-03-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.